Volume 10, Issue 1, Pages 29-36 (January 2013) Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: A multicenter case-control study Julia Köbe, MD, Florian Reinke, MD, Christian Meyer, MD, Dong-In Shin, MD, Eimo Martens, MD, Stefan Kääb, MD, Andreas Löher, MD, Susanne Amler, MSc, Artur Lichtenberg, MD,PhD, Joachim Winter, MD,PhD, Lars Eckardt, MD,PhD Heart Rhythm Volume 10, Issue 1, Pages 29-36 (January 2013) DOI: 10.1016/j.hrthm.2012.09.126 Copyright © 2013 Heart Rhythm Society Terms and Conditions
Figure 1 Results of intraoperative defibrillation capacity testing. ⊕ = successful termination; ∅ = nonsuccessful termination; CPR = cardiopulmonary resuscitation; ICD = implantable cardioverter-defibrillator; S-ICD = subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 2013 10, 29-36DOI: (10.1016/j.hrthm.2012.09.126) Copyright © 2013 Heart Rhythm Society Terms and Conditions
Figure 2 Severe hematoma after subcutaneous implantable cardioverter-defibrillator implantation requiring revision. Heart Rhythm 2013 10, 29-36DOI: (10.1016/j.hrthm.2012.09.126) Copyright © 2013 Heart Rhythm Society Terms and Conditions
Figure 3 Example of detection and conversion of ventricular fibrillation. Heart Rhythm 2013 10, 29-36DOI: (10.1016/j.hrthm.2012.09.126) Copyright © 2013 Heart Rhythm Society Terms and Conditions
Figure 4 Example of T-wave oversensing, inappropriate device discharge. Heart Rhythm 2013 10, 29-36DOI: (10.1016/j.hrthm.2012.09.126) Copyright © 2013 Heart Rhythm Society Terms and Conditions
Figure 5 Example of electromagnetic interference, nonsustained episode. Heart Rhythm 2013 10, 29-36DOI: (10.1016/j.hrthm.2012.09.126) Copyright © 2013 Heart Rhythm Society Terms and Conditions